Facebook Linkedin Soundcloud Twitter Vimeo Xing
Home Tags Immuno-oncology

Tag: immuno-oncology

AACR 2018: Highlighting Novel Antibody-Drug Conjugate Technologies and Immuno-Oncology

Peter Hofland
This year, the American Association for Cancer Research (AACR) will host their annual meeting April 14 - 18, 2018 in the McCormick Place North/South...

Nivolumab and DS-8201 to be Evaluated in HER2-Expressing Breast and Bladder...

Peter Hofland
Bristol-Myers Squibb and Daiichi Sankyo have agreed to collaborate in a clinical trial to evaluate the combination of Bristol-Myers Squibb’s immunotherapy nivolumab (Opdivo®) and...

F-star Implements Genedata Biologics as an Integrated Workflow Platform for Bispecific...

Peter Hofland
F-star, a clinical stage biopharmaceutical company developing bispecific antibody immuno-oncology products selected for their potential to transform the treatment of cancer, has licensed Genedata Biologics™...
ADC Review, Journal of Antibody-drug Conjugates
ADC Review, Journal of Antibody-drug Conjugates (ISSN 2327-0152) is an international peer-reviewed publication designed to serve the needs of a diverse community of individuals including academia, life sciences, pharma, research, clinicians and physicians. Along with regulatory affairs, we also cover government authorities and representatives from payers to policymakers.

Latest

Peer Review

© 2013-2020 Sunvalley Communication, LLC. All Rights Reserved.

X